The Regulation of Renal Phosphate Transport

Advances in Chronic Kidney Disease

Volumn 18, Issue 2, 2011, Pages 77-84

  Blaine, Judith ^a,c   Weinman, Edward J ^b   Cunningham, Rochelle ^b  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^b Department of Physiology ^*  (United States)

^c UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

Phosphate; Proximal tubule; PTH; Regulation; Transporters

Indexed keywords

CYTOSKELETON PROTEIN; DOPAMINE; ESTROGEN; GLUCOCORTICOID; PARATHYROID HORMONE; PHOSPHATONIN DERIVATIVE; SODIUM PHOSPHATE COTRANSPORTER; SOMATOMEDIN; THYROID HORMONE; UNCLASSIFIED DRUG;

CIRCADIAN RHYTHM; DIETARY INTAKE; HORMONAL REGULATION; HUMAN; HYPERTENSION; KIDNEY PROXIMAL TUBULE; KIDNEY TUBULE ABSORPTION; LIPID COMPOSITION; METABOLIC ACIDOSIS; NONHUMAN; PHOSPHATE TRANSPORT; POTASSIUM DEFICIENCY; PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION;

ABSORPTION; BIOLOGICAL TRANSPORT, ACTIVE; DOPAMINE; FIBROBLAST GROWTH FACTORS; HOMEOSTASIS; HORMONES; HUMANS; ION TRANSPORT; KIDNEY TUBULES, PROXIMAL; PARATHYROID HORMONE; PHOSPHATES; PHOSPHOPROTEINS; PHOSPHORUS, DIETARY; SIGNAL TRANSDUCTION; SODIUM-HYDROGEN ANTIPORTER; SODIUM-PHOSPHATE COTRANSPORTER PROTEINS;

EID: 79952585188     PISSN: 15485595     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ackd.2011.01.005     Document Type: Review

References (107)

1. Crook M., Swaminathan R. Disorders of plasma phosphate and indications for its measurement. Ann Clin Biochem 1996, 33(Pt 5):376-396.
2. Murer H., Hernando N., Forster I., et al. Proximal tubular phosphate reabsorption: molecular mechanisms. Physiol Rev 2000, 80:1373-1409.
3. Magagnin S., Werner A., Markovich D., et al. Expression cloning of human and rat renal cortex Na/Pi cotransport. Proc Natl Acad Sci USA 1993, 90:5979-5983.
4. Segawa H., Kaneko I., Takahashi A., et al. Growth-related renal type II Na/Pi cotransporter. J Biol Chem 2002, 277:19665-19672.
5. Villa-Bellosta R., Ravera S., Sorribas V., et al. The Na+-Pi cotransporter PiT-2 (SLC20A2) is expressed in the apical membrane of rat renal proximal tubules and regulated by dietary Pi. Am J Physiol Renal Physiol 2009, 296:F691-F699.
6. Beck L., Karaplis A.C., Amizuka N., et al. Targeted inactivation of Npt2 in mice leads to severe renal phosphate wasting, hypercalciuria, and skeletal abnormalities. Proc Natl Acad Sci USA 1998, 95:5372-5377.
7. Tenenhouse H.S., Martel J., Gauthier C., et al. Differential effects of Npt2a gene ablation and X-linked Hyp mutation on renal expression of Npt2c. Am J Physiol Renal Physiol 2003, 285:F1271-F1278.
8. Segawa H., Onitsuka A., Furutani J., et al. Npt2a and Npt2c in mice play distinct and synergistic roles in inorganic phosphate metabolism and skeletal development. Am J Physiol Renal Physiol 2009, 297:F671-F678.
9. Forster I.C., Hernando N., Biber J., et al. Proximal tubular handling of phosphate: a molecular perspective. Kidney Int 2006, 70:1548-1559.
10. Villa-Bellosta R., Sorribas V. Compensatory regulation of the sodium-phosphate cotransporters Napi-IIc (SLC34A3) and Pit-2 (SLC20A2) during Pi deprivation and acidosis. Pflugers Arch 2010, 459:499-508.
11. Azzarolo A.M., Ritchie G., Quamme G.A. Some characteristics of sodium-independent phosphate transport across renal basolateral membranes. Biochim Biophys Acta 1991, 1064:229-234.
12. Hoffman N., Thees M., Kinne R. Phosphate transport by isolated renal brush border vesicles. Pflugers Arch 1976, 362:147-156.
13. Bacconi A., Virkki L.V., Biber J., et al. Renouncing electroneutrality is not free of charge: switching on electrogenicity in a Na+-coupled phosphate cotransporter. Proc Natl Acad Sci USA 2005, 102:12606-12611.
14. Virkki L.V., Forster I.C., Biber J., et al. Substrate interactions in the human type IIa sodium-phosphate cotransporter (NaPi-IIa). Am J Physiol Renal Physiol 2005, 288:F969-F981.
15. Ravera S., Virkki L.V., Murer H., et al. Deciphering PiT transport kinetics and substrate specificity using electrophysiology and flux measurements. Am J Physiol Cell Physiol 2007, 293:C606-C620.
16. Virkki L.V., Biber J., Murer H., et al. Phosphate transporters: a tale of two solute carrier families. Am J Physiol Renal Physiol 2007, 293:F643-F654.
17. Breusegem S.Y., Takahashi H., Giral-Arnal H., et al. Differential regulation of the renal sodium-phosphate cotransporters Napi-IIa, NaPi-IIC, and PiT-2 in dietary potassium deficiency. Am J Physiol Renal Physiol 2009, 297:F350-F361.
18. Segawa H., Yamanaka S., Onitsuka A., et al. Parathyroid hormone-dependent endocytosis of renal type IIc Na-Pi cotransporter. Am J Physiol Renal Physiol 2007, 292:F395-F403.
19. Madjpour D., Bacic B., Kaissling H., et al. Segment-specific expression of sodium-phosphate cotransporters NaPi-IIa and-Iic and interacting proteins in mouse renal proximal tubules. Pflugers Arch 2004, 448:402-410.
20. Cunningham R., E X., Steplock D., Shenolikar S., Weinman E.J. Defective PTH regulation of sodium-dependent phosphate transport in NHERF-1-/- renal proximal tubule cells and wild-type cells adapted to low-phosphate media. Am J Physiol Renal Physiol 2005, 289:F933-F938.
21. Custer M., Spindler B., Verrey R., et al. Identification of a new gene product (diphor-1) regulated by dietary phosphate. Am J Physiol Renal Physiol 1997, 273:801-806.
22. Weinman E., Boddeti A., Cunningham R., et al. NHERF-1 is required for renal adaptation to a low-phosphate diet. Am J Physiol Renal Physiol 2007, 285:1225-1232.
23. Shenolikar S., Voltz J., Minkoff C.M., et al. Targeted disruption of the mouse gene encoding a PDZ domain-containing protein adaptor, NHERF-1, promotes Npt2 internalization and renal phosphate wasting. Proc Natl Acad Sci USA 2002, 99:11470-11475.
24. Capuano P., Bacic D., Stange G., et al. Expression and regulation of the renal Na/phosphate cotransporter NaPi-IIa in a mouse model deficient for the PDZ protein PDZK1. Pflugers Arch 2005, 449:392-402.
25. Zajicek H.K., Wang H., Puttaparthi K., et al. Glycosphingolipids modulate renal phosphate transport in potassium deficiency. Kidney Int 2001, 60:694-704.
26. Inoue M., Digman M.A., Cheng M., et al. Partitioning of NaPi cotransporter in cholesterol, sphingomyelin, NaPi protein diffusion, clustering and activity. J Biol Chem 2004, 279:49160-49171.
27. Deliot N., Hernando N., Horst-Liu Z., et al. Parathyroid hormone treatment induces dissociation of type IIa Na+-Pi cotransporter-Na+/H+ exchanger regulatory factor-1 complexes. Am J Physiol Cell Physiol 2005, 289:C159-C167.
28. Lotscher M., Scarpetta Y., Levi M., et al. Rapid downregulation of rat renal Na/Pi cotransporter in response to parathyroid hormone involves microtubule rearrangement. J Clin Invest 1998, 104:483-494.
29. Picard N.C., Stange G., Mihailova M., et al. Acute parathyroid hormone differentially regulates renal brush border membrane phosphate cotransporters. Pflugers Arch 2010, 460:677-687.
30. Capuano P., Bacic D., Roos M., et al. Defective coupling of apical PTH receptors to phospholipase C prevents internalization of the Na+-phosphate cotransporter NaPi-IIa in Nherf1-deficient mice. Am J Physiol Cell Physiol 2007, 292:C927-C934.
31. Lederer E.D., Khundmiri S.J., Weinman E.J. Role of NHERF-1 in regulation of the activity of Na-K ATPase and sodium-phosphate co-transport in epithelial cells. J Am Soc Nephrol 2003, 14:1711-1719.
32. Murer H., Forster I., Biber J. The sodium phosphate cotransporter family SLC34. Pflugers Arch 2004, 447:763-767.
33. Weinman E.J., Biswas R.S., Peng Q., et al. Parathyroid hormone inhibits renal phosphate transport by phosphorylation of serine 77 of sodium-hydrogen exchanger regulatory factor-1. J Clin Invest 2007, 117:3412-3420.
34. Karim Z., Gerard B., Bakouh N., et al. NHERF1 mutations and responsiveness of renal parathyroid hormone. N Engl J Med 2008, 359:1128-1135.
35. + exchanger regulatory factor 2 directs parathyroid hormone 1 receptor signaling. Nature 2002, 417:858-861.
36. Mahon M.J., Segre G.V. Stimulation by parathyroid hormone of a NHERF-1-assembled complex consisting of the parathyroid hormone I receptor, phospholipase Cβ, and actin increases intracellular calcium in opossum kidney cells. J Biol Chem 2004, 279:23550-23558.
37. Keusch I., Traebert M., Lotscher M., et al. Parathyroid hormone and dietary phosphate provoke a lysosomal routing of the proximal tubular Na/Pi-cotransporter type II. Kidney Int 1998, 54:1224-1232.
38. Pfister M.F., Ruf I., Stange G., et al. Parathyroid hormone leads to the lysosomal degradation of the renal type II Na/Pi cotransporter. Proc Natl Acad Sci USA 1998, 95:1909-1914.
39. Traebert M., Volkl H., Biber J., et al. Luminal and contraluminal action of 1-34 and 3-34 PTH peptides on renal type IIa Na-Pi cotransporter. Am J Physiol Renal Physiol 2000, 278:F792-F798.
40. Lederer E.D., Sohi S.S., McLeish K.R. Parathyroid hormone stimulates extracellular signal-regulated kinase (ERK) activity through two independent signal transduction pathways: role of ERK in sodium-phosphate cotransport. J Am Soc Nephrol 2000, 11:222-231.
41. Blaine J., Okamura K., Giral H., et al. PTH-induced internalization of apical membrane NaPi2a: role of actin and myosin VI. Am J Physiol Cell Physiol 2009, 297:C1339-C1346.
42. Anderson J., Foster J.B. The effect of cortisone on urinary phosphate excretion in man. Clin Sci 1959, 18:437-439.
43. Laron Z., Crawford J.D., Klein R. Phosphaturic effect of cortisone in normal and parathyroidectomized rats. Proc Soc Exp Biol Med 1957, 96:649-651.
44. Frick A., Durasin I. Proximal tubular reabsorption of inorganic phosphate in adrenalectomized rats. Pflugers Arch 1980, 385:189-192.
45. Levi M., Shayman J.A., Abe A., et al. Dexamethasone modulates rat renal brush border membrane phosphate transporter mRNA and protein abundance and glycosphingolipid composition. J Clin Invest 1995, 96:207-216.
46. Breusegem S.Y., Halaihel N., Inoue M., et al. Acute and chronic changes in cholesterol modulate Na-Pi cotransport activity in OK cells. Am J Physiol Renal Physiol 2005, 289:F154-F165.
47. Citrin D.L., Elson P., Kies M.S., et al. Decreased serum phosphate levels after high-dose estrogens in metastatic prostate cancer: possible implications. Am J Med 1984, 76:787-793.
48. Stock J.L., Coderre J.A., Mallette L.E. Effects of a short course of estrogen on mineral metabolism in postmenopausal women. J Clin Endocrinol Metab 1985, 61:595-600.
49. Beers K.W., Thompson M.A., Chini E.N., et al. [beta]-Estradiol inhibits Na+-Pi cotransport across renal brush border membranes from ovarectomized rats. Biochem Biophys Res Commun 1996, 221:442-445.
50. Faroqui S., Levi M., Soleimani M., et al. Estrogen downregulates the proximal tubule type IIa sodium phosphate cotransporter causing phosphate wasting and hypophosphatemia. Kidney Int 2008, 73:1141-1150.
51. Carrillo-Lopez N., Roman-Garcia, Rodriguez-Rebollar A., et al. Indirect regulation of PTH by estrogens may require FGF23. J Am Soc Nephrol 2009, 20:2009-2017.
52. Yamashita H., Yamazaki Y., Hasegawa H., et al. Fibroblast growth factor-23 in patients with graves' disease before and after antithyroid therapy: its important role in serum phosphate regulation. J Clin Endocrinol Metab 2005, 90:4211-4215.
53. Alcalde A.I., Sarasa M., Raldua D., et al. Role of thyroid hormone in regulation of renal phosphate transport in young and aged rats. Endocrinology 1999, 140:1544-1551.
54. Ishiguro M., Yamamoto H., Masuda M., et al. Thyroid hormones regulate phosphate homoeostasis through transcriptional control of the renal type IIa sodium-dependent phosphate co-transporter (Npt2a) gene. Biochem J 2010, 427:161-169.
55. Jehle A.W., Forgo J., Biber J., et al. IGF-I and vanadate stimulate Na/Pi-cotransport in OK cells by increasing type II Na/Pi-cotransporter protein stability. Pflugers Arch 1998, 437:149-154.
56. Caverzasio J., Montessuit C., Bonjour J.P. Stimulatory effect of insulin-like growth factor-1 on renal phosphate transport and plasma 1,25 dihydroxyvitamin D3. Endocrinology 1990, 127:453-459.
57. Bianda T., Hussain M.A., Glatz Y., et al. Effects of short-term insulin-like growth factor or growth hormone treatment on bone turnover, renal phosphate reabsorption, and 1,25 dihydroxyvitamin D3 production in healthy man. J Intern Med 1997, 241:143-150.
58. Cuche J.L., Marchand G.R., Greger R.F., et al. Phosphaturic effect of dopamine in dogs. Possible role of intrarenally produced dopamine in phosphate regulation. J Clin Invest 1976, 58:71-76.
59. Friedlander G. Autocrine/paracrine control of renal phosphate transport. Kidney Int Suppl 1998, 65:S18-S23.
60. Murphy M.B., Murray C., Shorten G.D. Fenoldapam: a selective peripheral dopamine-receptor agonist for the treatment of severe hypertension. N Engl J Med 2001, 345:1548-1557.
61. Baum M., Quigley R. Inhibition of proximal convoluted tubule transport by dopamine. Kidney Int 1998, 54:1593-1600.
62. Grider J., Kilpatrick E., Ott C., et al. Effect of dopamine on NaCl transport in the medullary thick ascending limb of the rat. Eur J Pharmacol 1998, 342:281-284.
63. Takemoto F., Cohen H.T., Satoh T., et al. Dopamine inhibits Na/K-ATPase in single tubule and cultured cells from distal nephron. Pflugers Arch 1992, 421:302-306.
64. Baines A.D., Drangova R. Does dopamine use several signal pathways to inhibit Na-Pi transport in OK cells?. J Am Soc Nephrol 1998, 9:1604-1612.
65. Bacic D., Capuano P., Baum M., et al. Activation of dopamine D1-like receptors induces acute internalization of the renal Na+/phosphate cotransporter NaPi-IIa in mouse kidney and OK cells. Am J Physiol Renal Physiol 2005, 288:F740-F747.
66. Lederer E.D., Sohl S.S., McLeish K.R. Dopamine regulates phosphate uptake by opossum kidney cells through multiple counter-regulatory receptors. J Am Soc Nephrol 1998, 9:975-985.
67. Perrichot R., Garcia-Ocana A., Couette S., et al. Locally formed dopamine modulates renal Na-Pi cotransport through DA1 and DA2 receptors. Biochem J 1995, 312:433-437.
68. Isaac J., Glahn R.P., Appel M.M., et al. Mechanism of dopamine inhibition of renal phosphate transport. J Am Soc Nephrol 1992, 2:1601-1607.
69. Cunningham R., Biswas R., Brazie M., et al. Signaling pathways utilized by PTH and dopamine to inhibit phosphate transport in mouse renal proximal tubule cells. Am J Physiol Renal Physiol 2009, 296:F355-F361.
70. Hall R.A., Lefkowitz R.J. Regulation of G protein-coupled receptor signaling by scaffold proteins. Circ Res 2002, 91:672-680.
71. Hall R.A., Premont R.T., Chow C.W., et al. The beta2-adrenergic receptor interacts with the Na+/H+-exchanger regulatory factor to control Na+/H+ exchange. Nature 1998, 392:626-630.
72. + exchanger regulatory factor-1 in rat osteosarcoma ROS 17/2.8 cells. Mol Endocrinol 2008, 22:1163-1170.
73. Weinman E.J., Biswas R., Steplock D., et al. Sodium-hydrogen exchanger regulatory factor 1 (NHERF-1) transduces signals that mediate dopamine inhibition of sodium-phosphate co-transport in mouse kidney. J Biol Chem 2010, 285:13454-13460.
74. Georgaki H., Puschett J.B. Influence of vitamin D status and chronic administration on the renal tubular effects of 1,25-dihydroxyvitamin D3. Proc Soc Exp Biol Med 1983, 174:86-92.
75. Kurnik B.R., Hruska K.A. Mechanism of stimulation of renal phosphate transport by 1,25-dihydroxycholecalciferol. Biochim Biophys Acta 1985, 817:42-50.
76. Sommer S., Berndt T., Craig T., Kumar R. The phosphatonins and the regulation of phosphate transport and vitamin D metabolism. J Steroid Biochem Mol Biol 2007, 103:497-503.
77. Baran D.T. Nongenomic actions of the steroid hormone 1,25 dihydroxyvitamin D3. J Cell Biochem 1994, 56:303-306.
78. Berndt T.J., Knox F.G. Renal regulation of phosphate excretion. The Kidney, Physiology and Pathophysiology 1992, 2511-2532. Raven, New York, NY. D.W. Seldin, G. Giebisch (Eds.).
79. Bonjour J.P., Caverzasio J. Phosphate transport in the kidney. Rev Physiol Biochem Pharmacol 1984, 100:161-214.
80. Dennis V.W. Phosphate homeostasis. Handbook of Physiology. Renal Physiology 1992, 1785-1815. American Physiology Society, Bethesda, MD.
81. Elgavish A., Rifkind H., Sactor B. In vitro effects of vitamin D3 on the phospholipids of isolated Rena brush-border membranes. J Memb Biol 1983, 72:85-91.
82. Suzuki M., Kawaguchi Y., Momose M., Morita T., Yokoyama K., Miyahara T. 1,25-Dihydroxyvitamin D stimulates sodium-dependent phosphate transport by renal outer cortical brush-border membrane vesicles by directly affecting membrane fluidity. Biochem Biophys Res Commun 1988, 150:1193-1198.
83. Berndt T.J., Kumar R. Phosphatonins and the regulation of phosphate homeostasis. Annu Rev Physiol 2007, 69:341-359.
84. Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23. Nat Genet 2000, 26:345-348. ADHR Consortium.
85. Shimada T., Mizutani S., Muto T., et al. Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia. Proc Natl Acad Sci USA 2001, 98:6500-6505.
86. Larsson T., Marsell R., Shipani E., et al. Transgenic mice expressing fibroblast growth factor 23 under the control of the alpha (I) collagen promoter exhibit growth retardation osteomalacia, and disturbed phosphate homeostasis. Endocrinology 2004, 145:3087-3094.
87. Bai X., Miao D., Li J., et al. Transgenic mice overexpressing human fibroblast growth factor 23 (R176Q) delineate a putative role for parathyroid hormone in renal phosphate wasting disorders. Endocrinology 2004, 145:5269-5279.
88. Shimada T., Kakitana M., Yamazaki Y., et al. Targeted ablation of FGF23 demonstrates an essential physiological role of FGF23 in phosphate and vitamin D metabolism. J Clin Invest 2004, 113:561-568.
89. Sitara D., Razzaque M.S., Hesse M., et al. Homozygous ablation of fibroblast growth factor-23 results in hyperphosphatemia and impaired skeletogenesis, and reverses hypophosphatemia in Phex-deficient mice. Matrix Biol 2004, 23:421-432.
90. Topaz O., Shurman D.L., Bergman R., et al. Mutations in GALNT3, encoding a protein involved in O-linked glycosylation, cause familial tumoral calcinosis. Nat Genet 2004, 36:579-581.
91. Benet-Pages A., Orlik P., Strom T.M., et al. An FGF23 missense mutation causes familial tumoral calcinosis with hyperphosphatemia. Hum Mol Genet 2005, 14:385-390.
92. Larsson T., Davis S.I., Garringer H.J., et al. Fibroblast growth factor-23 mutants causing familia calcinosis are differentially processed. Endocrinology 2005, 146:3883-3891.
93. Larsson T., Nisbeth U., Ljunggren O., et al. Circulating concentration of FGF-23 increases as renal function declines in patients with chronic kidney disease, but does not change in response to variation in phosphate intake in healthy volunteers. Kidney Int 2003, 64:2272-2279.
94. Imanishi Y., Inaba M., Nakatsuka K., et al. FGF-23 in patients with end-stage renal disease on hemodialysis. Kidney Int 2004, 65:1943-1946.
95. Komaba H., Goto S., Fujii H., et al. Depressed expression of Klotho and FGF receptor 1 in hyperplastic parathyroid glands from uremic patients. Kidney Int 2010, 77:232-238.
96. Bhan I., Shah A., Holmes J., et al. Post-transplant hypophosphatemia: tertiary "hyper-phosphatoninism" ?. Kidney Int 2006, 70:1486-1494.
97. Evenepoel P., Naesens M., Claes K., et al. Tertiary "hyper-phosphatoninism" accentuates hypophosphatemia and suppresses calcitriol levels in renal transplant recipients. Am J Transplant 2007, 7:1193-1200.
98. Evenepoel P., Meijers B.K., de Jonge H., et al. Recovery of hyper-phosphatoninism and renal phosphorus wasting one year after successful renal transplantation. Clin J Am Soc Nephrol 2008, 3:1829-1836.
99. Sato T., Fukagawa M., Uchida K., et al. 1,25-Dihdroxyvitamin D synthesis after renal transplantation: the role of fibroblast growth factor 23 and cyclosporine. Clin Transplant 2009, 23:368-374.
100. Gutierrez O.M., Mannstadt M., Isakkova T., et al. Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis. N Engl J Med 2008, 359:584-592.
101. Jean G., Terrat J.C., Vanel T., et al. High levels of serum fibroblast growth factor 23 are associated with increased mortality in long hemodialysis patients. Nephrol Dial Transplant 2009, 24:2792-2796.
102. Magyar C.E., Zhang Y., Holstein-Rathlou H., et al. Proximal tubule Na transporter responses are the same during acute and chronic hypertension. Am J Physiol Renal Physiol 2000, 279:F358-F369.
103. Riquier A.D., Lee D.H., McDonough A.A. Renal NHE3 and Napi2 partition into distinct membrane domains. Am J Physiol Cell Physiol 2009, 296:C900-C910.
104. Zhang Y., Magyar C.E., Norian J.M., et al. Reversible effects of acute hypertension on proximal tubule sodium transporter. Am J Physiol 1998, 274(4 Pt 1):C1090-C1100.
105. Ambuhl P.M., Zajicek H.K., Wang H., et al. Regulation of renal phosphate transport by acute and chronic metabolic acidosis in the rat. Kidney Int 1998, 53:1288-1298.
106. Nowik M., Picard N., Stange G., et al. Renal phosphaturia during metabolic acidosis revisited: molecular mechanism for decreased renal phosphate reabsorption. Pflugers Arch 2008, 457:539-549.
107. Bielesz B., Bacic D., Honegger K., et al. Unchanged expression of the sodium-phosphate cotransporter NaPi-IIa despite diurnal changes in renal phosphate excretion. Pflugers Arch 2006, 452:683-689.